aTyr Pharma, Inc.
(NASDAQ: ATYR)
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
0.828
+0.057
(+7.39%)
Range
0.752 - 0.863
(14.76%)
Open
0.752
Previous Close
0.771
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
3,199,903
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
